48 results on '"Cuervas‐Mons, V"'
Search Results
2. Long-Term Survivors After Pediatric Liver Transplatation Are at Increased Risk for Development of Cardiovascular Disease Events: Analysis of 30 Cases
3. CC Genotype at rs12979860 of IL28B Is Associated With Lower Risk of New-onset Diabetes After Transplantation in Adult Patients With Liver Transplantation for Hepatitis C Cirrhosis
4. TT Genotype of Transforming Growth Factor Beta1 +869C/T Is Associated With the Development of Chronic Kidney Disease After Liver Transplantation
5. Toll-like Receptor 3 L412F Polymorphism May Protect Against Acute Graft Rejection in Adult Patients Undergoing Liver Transplantation for Hepatitis C-Related Cirrhosis
6. Breakthrough Rhinocerebral Mucormycosis in a Liver Transplant Patient Receiving Caspofungin
7. Right Adrenal Metastases of Hepatocarcinoma After Liver Transplantation: Case Report and Literature Review
8. Five-Year Follow-up of a Trial Comparing Tacrolimus and Cyclosporine Microemulsion in Liver Transplantation
9. Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation
10. Usefulness of mycophenolate mofetil in patients with chronic renal insufficiency after liver transplantation
11. De novo malignancies in liver transplantation
12. Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients
13. Influence of Infection by Aspergillus in Arterial Complications After Liver Transplantation: Evolution and Results in 670 Transplants
14. Hepatitis C Virus Sensitivity to Combined Antiviral Therapy in Liver Transplant Versus Immunocompetent Patients
15. Incidence and outcome of De Novo malignancies after liver transplantation
16. Late orthotopic liver retransplant: indications and survival
17. Influence of antiviral therapy on the natural history of hepatitis B virus recurrence after liver transplantation: retrospective study of 14 cases
18. Results of Liver Transplantation in Patients With Previous Portosystemic Shunts
19. Therapy of Intractable Pruritus With MARS
20. De novo malignancies and liver transplantation
21. Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality
22. Cardiovascular morbidity and obesity in adult liver transplant recipients
23. Effectiveness of low-dose intramuscular Anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: preliminary report
24. Usefulness of chemotherapy as prophylaxis of tumor recurrence after liver transplantation in advanced hepatocellular carcinomas
25. Recurrence of primary biliary cirrhosis after liver transplantation
26. Induction of peripheral chimerism in an allogenic model of small bowel transplantation with intrathymic inoculation of donor-derived cells
27. Risk Factors for Clostridioides Difficile Diarrhea In Solid Organ Transplantation Recipients.
28. Autoimmune Extrahepatic Disorders in Patients With Autoimmune Liver Disease.
29. Preface.
30. Preface.
31. Preface.
32. Is the use of University of Wisconsin solution with prolonged ischemia time an option in clinical liver transplantation?
33. Prolonged graft cold ischemia: a risk factor for early bacterial and fungal infection in liver transplant recipients.
34. Renal failure after liver transplantation: analysis of risk factors in 139 liver transplant recipients.
35. Is liver transplantation an emergency or an elective surgical procedure? Analysis of risk factors related to early mortality in 139 liver transplant recipients.
36. Prospective study of the incidence, timing, significance, risk factors, and outcome of cytomegalovirus infection in liver transplant patients with double-drug immunosuppression and no prophylactic antiviral therapy.
37. Incidence and risk factors of early acute renal failure in liver transplant patients.
38. Kidney function following orthotopic liver transplantation and its relationship to arterial hypertension.
39. Prognostic value of the APACHE II, SAPS, and TISS indexes in short-term survival of liver transplant patients.
40. Renin-angiotensin-aldosterone system and arterial hypertension following orthotopic liver transplantation.
41. Value of histologic findings in predicting the response to treatment of acute graft rejection after liver transplantation.
42. Isolation of hepatocytes followed by transplantation into the spleen in experimental fulminant hepatic failure.
43. Analysis of cytomegalovirus reactivation after liver transplantation in cytomegalovirus immunoglobulin G antibody seropositive patients prior to transplantation.
44. Intrasplenic hepatocellular transplantation as a hepatic support measure in cirrhotic dogs: preliminary results.
45. Bacterial infections in liver transplant patients under selective decontamination with norfloxacin.
46. Effect of intrasplenic hepatocellular allotransplantation in homozygous Gunn rats using cyclosporine as immunosuppressor.
47. Monitoring of the rejection of intrasplenic hepatocyte allografts and xenografts in the rat using technetium 99m-imidoacetic acid scanning.
48. Metabolic effects of liver replacement in homozygous familial hypercholesterolemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.